{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:19:04Z","timestamp":1790216344208,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jaad.2017.12.010","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T22:20:59Z","timestamp":1512771659000},"page":"776-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"title":["Anti-melanoma differentiation\u2013associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features"],"prefix":"10.1016","volume":"78","author":[{"given":"Drew J.B.","family":"Kurtzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Vleugels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2017.12.010_bib1","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.jaad.2017.12.010_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jaad.2017.12.010_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","article-title":"The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody","volume":"49","author":"Nakashima","year":"2010","journal-title":"Rheumatology"},{"issue":"6-7","key":"10.1016\/j.jaad.2017.12.010_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biochi.2007.01.013","article-title":"Triggering antiviral response by RIG-I-related RNA helicases","volume":"89","author":"Fujita","year":"2007","journal-title":"Biochimie"},{"issue":"11","key":"10.1016\/j.jaad.2017.12.010_bib5","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/art.1780291109","article-title":"Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis","volume":"29","author":"Christensen","year":"1986","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jaad.2017.12.010_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1073\/pnas.022637199","article-title":"MDA-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties","volume":"99","author":"Kang","year":"2002","journal-title":"Proc Natl Acad Sci United States America"},{"issue":"11","key":"10.1016\/j.jaad.2017.12.010_bib7","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jaad.2017.12.010_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon beta is associated with type 1 interferon-inducible gene expression in dermatomyositis","volume":"70","author":"Liao","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.12.010_bib9","article-title":"Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon beta in dermatomyositis","author":"Huard","year":"2016","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.12.010_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/ker408","article-title":"Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM\/interstitial lung disease during disease remission","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib11","doi-asserted-by":"crossref","first-page":"e0154285","DOI":"10.1371\/journal.pone.0154285","article-title":"Clinical utility of an enzyme-linked immunosorbent assay for detecting anti-melanoma differentiation-associated gene 5 autoantibodies","volume":"11","author":"Sato","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jaad.2017.12.010_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","article-title":"Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera","volume":"433","author":"Cavazzana","year":"2016","journal-title":"J immunological Methods"},{"issue":"3","key":"10.1016\/j.jaad.2017.12.010_bib13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","article-title":"Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study","volume":"147","author":"Hamaguchi","year":"2011","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.12.010_bib15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/14397595.2014.896494","article-title":"Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients","volume":"24","author":"Kang","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10.1016\/j.jaad.2017.12.010_bib17","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acr.21728","article-title":"Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody","volume":"64","author":"Cao","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.jaad.2017.12.010_bib18","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/acr.21985","article-title":"Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.jaad.2017.12.010_bib19","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jaad.2017.12.010_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjd.14882","article-title":"Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis","volume":"176","author":"Matsushita","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.12.010_bib21","first-page":"e43","article-title":"Rapid increase of serum anti-MDA-5 antibodies and exacerbation of clinically amyopathic dermatomyositis\/interstitial lung disease. Journal of the European Academy of Dermatology and Venereology","volume":"31","author":"Murase","year":"2017","journal-title":"JEADV"},{"issue":"9","key":"10.1016\/j.jaad.2017.12.010_bib22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/s10165-011-0558-9","article-title":"Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140\/MDA5 autoantibodies","volume":"22","author":"Sato","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.12.010_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.12.010_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/acr.22498","article-title":"Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease","volume":"67","author":"Narang","year":"2015","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e3182606f0b","article-title":"A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature","volume":"91","author":"Chaisson","year":"2012","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.jaad.2017.12.010_bib27","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.jaad.2017.12.010_bib28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","article-title":"Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum","volume":"65","author":"Hall","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaad.2017.12.010_bib29","doi-asserted-by":"crossref","first-page":"290797","DOI":"10.1155\/2014\/290797","article-title":"Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis","volume":"2014","author":"Labrador-Horrillo","year":"2014","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.jaad.2017.12.010_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3899\/jrheum.160682","article-title":"Antimelanoma differentiation-associated gene 5 antibody: expanding the clinical spectrum in North American patients with dermatomyositis","volume":"44","author":"Moghadam-Kia","year":"2017","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.12.010_bib31","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3899\/jrheum.160024","article-title":"Gottron papules and Gottron sign with ulceration: a distinctive cutaneous feature in a subset of patients with classic dermatomyositis and clinically amyopathic dermatomyositis","volume":"43","author":"Cao","year":"2016","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-91-4-577","article-title":"A cutaneous lesion associated with myositis","volume":"91","author":"Stahl","year":"1979","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jaad.2017.12.010_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2133.2006.07593.x","article-title":"\u201cMechanic's hands\u201d: a misleading cutaneous sign of the antisynthetase syndrome","volume":"156","author":"Bachmeyer","year":"2007","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.12.010_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/bjd.14801","article-title":"Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositis","volume":"176","author":"Ang","year":"2017","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.12.010_bib35","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.rmed.2011.05.006","article-title":"HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody","volume":"105","author":"Tanizawa","year":"2011","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.jaad.2017.12.010_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.rmed.2013.01.014","article-title":"The prognostic value of HRCT in myositis-associated interstitial lung disease","volume":"107","author":"Tanizawa","year":"2013","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.jaad.2017.12.010_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/bjd.14771","article-title":"Pulmonary function tests, interstitial lung disease and lung function decline in outpatients with classic and clinically amyopathic dermatomyositis","volume":"176","author":"George","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.12.010_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1471-2474-11-223","article-title":"Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis","volume":"11","author":"Kang","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"6","key":"10.1016\/j.jaad.2017.12.010_bib39","first-page":"891","article-title":"Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis","volume":"32","author":"Ceribelli","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/03009740802687455","volume":"38","author":"Fujikawa","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-2007-985666","article-title":"Pulmonary complications of polymyositis and dermatomyositis","volume":"28","author":"Fathi","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jaad.2017.12.010_bib42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archdermatol.2010.134","article-title":"Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations","volume":"146","author":"Morganroth","year":"2010","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.12.010_bib43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acr.22728","article-title":"Anti-melanoma differentiation-associated gene 5 is associated with rapidly progressive lung disease and poor survival in US patients with amyopathic and myopathic dermatomyositis","volume":"68","author":"Moghadam-Kia","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.jaad.2017.12.010_bib44","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1007\/s00296-011-2323-y","article-title":"Anti-MDA5 antibody is associated with A\/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis","volume":"32","author":"Chen","year":"2012","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.jaad.2017.12.010_bib45","first-page":"903","article-title":"Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis","volume":"33","author":"Funauchi","year":"2006","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.12.010_bib46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1309\/CNQDMHLH2WGKL32T","article-title":"The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease","volume":"127","author":"Magro","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.jaad.2017.12.010_bib47","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.rmed.2015.07.004","article-title":"Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis","volume":"109","author":"Takada","year":"2015","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.jaad.2017.12.010_bib48","first-page":"30","article-title":"Four cases of interstitial pneumonia associated with amyopathic dermatomyositis characterized by the anti-CADM-140 antibody","volume":"49","author":"Nagata","year":"2011","journal-title":"Nihon Kokyuki Gakkai zasshi\u00a0= J Jpn Respir Soc"},{"key":"10.1016\/j.jaad.2017.12.010_bib49","first-page":"5","article-title":"Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis","volume":"19","author":"Suzuki","year":"2016","journal-title":"Respir Med case Rep"},{"issue":"2","key":"10.1016\/j.jaad.2017.12.010_bib50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10067-015-3001-3","article-title":"Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum","volume":"35","author":"Ma","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.jaad.2017.12.010_bib51","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s11606-016-3769-0","article-title":"Anti-MDA5-positive dermatomyositis presenting as fever of unknown origin","volume":"31","author":"Lee","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"9250","key":"10.1016\/j.jaad.2017.12.010_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2017.12.010_bib53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1361.047","article-title":"Cancer-associated myositis: clinical features and prognostic signs","volume":"1051","author":"Ponyi","year":"2005","journal-title":"Ann New York Acad Sci"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib54","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2017.12.010_bib55","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/ced.12674","article-title":"Amyophatic dermatomyositis presenting as a flagellated skin eruption with positive MDA5 antibodies and thyroid cancer: a real association?","volume":"40","author":"Molina-Ruiz","year":"2015","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib56","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1684\/ejd.2014.2381","article-title":"Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer","volume":"24","author":"Yamaoka","year":"2014","journal-title":"Eur J Dermatol: EJD"},{"issue":"2","key":"10.1016\/j.jaad.2017.12.010_bib57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5152\/eurjrheum.2015.0076","article-title":"High-dose intravenous immunoglobulin therapy for rapidly progressive interstitial pneumonitis accompanied by anti-melanoma differentiation-associated gene 5 antibody-positive amyopathic dermatomyositis","volume":"2","author":"Hamada-Ode","year":"2015","journal-title":"Eur J Rheumatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.12.010_bib58","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jaad.2017.12.010_bib59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/s10165-010-0371-x","article-title":"Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis","volume":"21","author":"Gono","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.12.010_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/s10165-012-0637-6","article-title":"Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases","volume":"23","author":"Horai","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.12.010_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10067-016-3443-2","article-title":"Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies","volume":"36","author":"Hayashi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2017.12.010_bib62","article-title":"Potential inhibition of development of rapidly progressive interstitial lung disease by prompt and sufficient immunosuppressive treatment in patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis","author":"Shu","year":"2016","journal-title":"J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2017.12.010_bib63","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1191\/0961203305lu2170oa","article-title":"Modulation of intra-pulmonary TGF-beta expression by mycophenolate mofetil in lupus prone MRL\/lpr mice","volume":"14","author":"Guo","year":"2005","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.jaad.2017.12.010_bib64","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.12.010_bib65","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.jaad.2017.12.010_bib66","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/acr.20212","article-title":"Mycophenolate mofetil for interstitial lung disease in dermatomyositis","volume":"62","author":"Morganroth","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.jaad.2017.12.010_bib67","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2013.06.007","article-title":"Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center","volume":"69","author":"Femia","year":"2013","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217327640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217327640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:45:30Z","timestamp":1759272330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217327640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0190962217327640"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.12.010","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-melanoma differentiation\u2013associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}